Cathepsin D as biomarker in cerebrospinal fluid of nusinersen-treated patients with spinal muscular atrophy

Medicine & Life Sciences

• nusinersen 100%
• Cathepsin D 71%
• Spinal Muscular Atrophy 70%
• Cerebrospinal Fluid 47%
• Biomarkers 35%
• Spinal Muscular Atrophies of Childhood 16%
• Intermediate Filaments 11%
• Proteomics 10%
• Light 7%
• Therapeutics 6%
• Peptide Hydrolases 4%
• Decision Making 4%
• Enzyme-Linked Immunosorbent Assay 3%
• Down-Regulation 3%
• Western Blotting 3%
• Pediatrics 3%
• Biopsy 3%
• Muscles 3%
• Proteins 2%